HHS Carcinogen Report Updated to Include 8 Substances
The US Department of HHS added 8 new substances to the 15th Report on Carcinogens, bringing the total list to 256 substances.
Poisoning/overdose
Illicitly Manufactured Fentanyl-Involved Deaths Increased 2019 to 2020
Sharp increase in deaths in Midwestern, Southern, Western jurisdictions; stimulant also involved in about four of 10 IMF-involved deaths
E-Cigarettes May Up the Risk for Erectile Dysfunction
Findings for men between 20 and 65 years of age with no prior history of cardiovascular disease
CDC: More Than 100,000 Americans Died From Drug Overdoses in 1 Year
Figure is almost 30 percent higher than the previous year, when 78,000 overdose deaths were reported
Expert Panel Sees Challenges With Federally Mandated Opioid Prescriber Education
During the workshop, speakers and panelists reviewed past programs that were put into place to reduce opioid prescribing, as well as trends in opioid prescribing and overdose deaths.
MPR Weekly Dose Podcast Episode 99
This week on the pod, there’s positive news for the COVID-19 oral antiviral candidate, Paxlovid; The CDC expands a recall for aromatherapy sprays connected to fatal cases of a rare tropical disease; The first eye drop to treat presbyopia is approved; An alternative to naloxone gets fast tracked; And a study compares the migraine treatments erenumab and topiramate.
Intranasal Nalmefene Fast Tracked for Opioid Overdose Treatment
The investigational intranasal formulation of nalmefene demonstrated a more rapid onset and longer duration of action compared with naloxone.
AHA: E-Cigarette Use Linked to Risk for Stroke at a Younger Age
Prevalence of e-cigarette use higher than traditional smoking for women, Mexican Americans, other Hispanics
Poisoning Related to Ivermectin Exposure for COVID-19 Described
In August 2021, 21 calls were received by Oregon Poison Center; six people were hospitalized for toxic effects resulting from use
MPR Weekly Dose Podcast Episode 97
This week: The FDA authorize boosters for Moderna and Janssen and okay ‘mixing and matching’ of vaccines for the booster dose. The first interchangeable biosimilar to Humira is approved. Also there’s approvals in dry eye disease, pain management and opioid overdoses.
